(Q24235224)

English

Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)

scientific article (publication date: 9 November 2011)

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome) (English)

0 references

main subject

enzyme replacement therapy

0 references

1 reference

Edina MK da Silva

1

0 references

Maria Wany Louzada Strufaldi

series ordinal

3

0 references

Régis B Andriolo

series ordinal

4

0 references

Laercio A Silva

series ordinal

5

0 references

publication date

9 November 2011

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

21 January 2018

First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

21 January 2018

Meta-analyses involving cross-over trials: methodological issues

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

21 January 2018

Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

21 January 2018

Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

21 January 2018

Prevalence of lysosomal storage disorders

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

21 January 2018

Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

21 January 2018

Mucopolysaccharidosis type II in females: case report and review of literature.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

21 January 2018

Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

21 January 2018

Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

21 January 2018

Enzymic diagnosis of the genetic mucopolysaccharide storage disorders

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008185.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD008185.PUB2

0 references

PubMed publication ID

22071845

0 references

(Q24235224)

Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)